613 Neoadjuvant SEMA4D Blockade with Nivolumab Alters Suppressive Myeloid Cells While Elevating B Cell and CD26hiT Cell Infiltration in the Tumors of Patients with Resectable Stage III Melanoma
Regular and Young Investigator Award Abstracts（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined